{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:07:18Z","timestamp":1793729238963,"version":"4.6.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2025JJ90041"],"award-info":[{"award-number":["2025JJ90041"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014978","name":"Hunan University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.acra.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T01:26:45Z","timestamp":1758590805000},"page":"7260-7280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of Prostate-Specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities in the Detection of Biochemical Recurrence of Prostate Cancer and Assessment of the Role of Artificial Intelligence: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Haiying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2025.09.004_bib1","article-title":"The contemporary management of prostate cancer","author":"Chakrabarti","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib2","first-page":"308","article-title":"Cancer treatment and survivorship statistics, 2025","volume":"75","author":"Wagle","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"10437","key":"10.1016\/j.acra.2025.09.004_bib3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.eururo.2021.07.027","article-title":"Risk stratification of patients candidate to radical prostatectomy based on clinical and multiparametric magnetic resonance imaging parameters: development and external validation of novel risk groups","volume":"81","author":"Mazzone","year":"2022","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib5","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.euo.2025.05.026","article-title":"Epidemiology of high-risk biochemical recurrence after primary prostate cancer treatment","volume":"8","author":"Falagario","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"16","key":"10.1016\/j.acra.2025.09.004_bib6","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.23.01391","article-title":"Salvage reirradiation for locally recurrent prostate cancer: results from a prospective study with 7.2 years of follow-up","volume":"42","author":"Ekanger","year":"2024","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70193","article-title":"Minimal residual disease detection: implications for clinical diagnosis and cancer patient treatment","volume":"6","author":"Song","year":"2025","journal-title":"MedComm"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00259-024-06949-7","article-title":"Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS\u2009\u2264\u20093 MRI","volume":"52","author":"Li","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1131","key":"10.1016\/j.acra.2025.09.004_bib9","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210728","article-title":"Prostate-specific membrane antigen (PSMA) fusion imaging in prostate cancer: PET-CT vs PET-MRI","volume":"95","author":"Liu","year":"2022","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41391-023-00755-2","article-title":"Comparison of (18)F-based PSMA radiotracers with [(68)Ga]Ga-PSMA-11 in PET\/CT imaging of prostate cancer-a systematic review and meta-analysis","volume":"27","author":"Huang","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.crad.2024.02.008","volume":"79","author":"Jiang","year":"2024","journal-title":"Clin Radiol"},{"key":"10.1016\/j.acra.2025.09.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115966","article-title":"A systematic review on the current status of PSMA-targeted imaging and radioligand therapy","volume":"263","author":"Capasso","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib13","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.243352","article-title":"Building the foundation for AI in prostate cancer imaging","volume":"315","author":"Westphalen","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2025.09.004_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07426-5","article-title":"AI lesion tracking in PET\/CT imaging: a proposal for a Siamese-based CNN pipeline applied to PSMA PET\/CT scans","author":"Hein","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41698-025-00934-5","article-title":"Mitigating bias in prostate cancer diagnosis using synthetic data for improved AI driven Gleason grading","volume":"9","author":"Van Booven","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12910-025-01243-z","article-title":"Evaluating accountability, transparency, and bias in AI-assisted healthcare decision- making: a qualitative study of healthcare professionals' perspectives in the UK","volume":"26","author":"Nouis","year":"2025","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.acra.2025.09.004_bib17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"8","key":"10.1016\/j.acra.2025.09.004_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.acra.2025.09.004_bib19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"10.1016\/j.acra.2025.09.004_bib20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","article-title":"Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations","volume":"12","author":"Moses","year":"1993","journal-title":"Stat Med"},{"issue":"9","key":"10.1016\/j.acra.2025.09.004_bib21","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11307-015-0866-0","article-title":"Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET imaging in patients with relapsed prostate cancer","volume":"17","author":"Dietlein","year":"2015","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2967\/jnumed.116.185538","article-title":"PSA-stratified performance of (18)F- and (68)Ga-PSMA PET in patients with biochemical recurrence of prostate cancer","volume":"58","author":"Dietlein","year":"2017","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.acra.2025.09.004_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2967\/jnumed.119.234898","article-title":"Intraindividual comparison of (18)F-PSMA-1007 with renally excreted PSMA ligands for PSMA PET Imaging in Patients with Relapsed Prostate Cancer","volume":"61","author":"Dietlein","year":"2020","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1148\/radiol.2020192018","article-title":"Evaluating biochemically recurrent prostate cancer: histologic validation of (18)F-DCFPyL PET\/CT with comparison to multiparametric MRI","volume":"296","author":"Lindenberg","year":"2020","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.acra.2025.09.004_bib26","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00259-022-05693-0","article-title":"Diagnostic accuracy of [(18)F]PSMA-1007 PET\/CT in biochemical recurrence of prostate cancer","volume":"49","author":"Mingels","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.acra.2025.09.004_bib27","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2967\/jnumed.119.226381","article-title":"A prospective study on (18)F-DCFPyL PSMA PET\/CT imaging in biochemical recurrence of prostate cancer","volume":"60","author":"Rousseau","year":"2019","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2967\/jnumed.119.229187","article-title":"Matched-pair comparison of (68)Ga-PSMA-11 PET\/CT and (18)F-PSMA-1007 PET\/CT: frequency of pitfalls and detection efficacy in biochemical recurrence after radical prostatectomy","volume":"61","author":"Rauscher","year":"2020","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2967\/jnumed.119.226514","article-title":"Prospective evaluation of PSMA-targeted (18)F-DCFPyL PET\/CT in men with biochemical failure after radical prostatectomy for prostate cancer","volume":"61","author":"Rowe","year":"2020","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2967\/jnumed.119.231654","article-title":"Prospective evaluation of (18)F-DCFPyL PET\/CT in biochemically recurrent prostate cancer in an academic center: a focus on disease localization and changes in management","volume":"61","author":"Song","year":"2020","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.120.246363","article-title":"Diagnostic accuracy of (18)F-PSMA-1007 PET\/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence","volume":"62","author":"Sprute","year":"2021","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41391-019-0194-6","article-title":"Diagnostic performance of 18F-PSMA-1007 PET\/CT in biochemically relapsed patients with prostate cancer with PSA levels\u2009\u2264\u20092.0\u2009ng\/ml","volume":"23","author":"Witkowska-Patena","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib33","first-page":"178","article-title":"A comparison of the diagnostic performance of (18)F-PSMA-1007 and (68)GA-PSMA-11 in the same patients presenting with early biochemical recurrence","volume":"24","author":"Lengana","year":"2021","journal-title":"Hell J Nucl Med"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib34","article-title":"Utilization of salvage and systemic therapies for recurrent prostate cancer as a result of (18)F-DCFPyL PET\/CT restaging","volume":"6","author":"Liu","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bju.14506","volume":"124","author":"van Leeuwen","year":"2019","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.acra.2018.05.020","article-title":"68)Ga-PSMA PET\/CT in patients with rising prostatic-specific antigen after definitive treatment of prostate cancer: detection efficacy and diagnostic accuracy","volume":"26","author":"Hamed","year":"2019","journal-title":"Acad Radiol"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib37","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.7150\/thno.18421","article-title":"Diagnostic accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET\/CT before salvage lymph node dissection for recurrent prostate cancer","volume":"7","author":"Jilg","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euf.2018.07.025","article-title":"Accuracy of (68)Ga-prostate-specific membrane antigen positron emission tomography for the detection of lymph node metastases before salvage lymphadenectomy","volume":"6","author":"Mandel","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"8","key":"10.1016\/j.acra.2025.09.004_bib39","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00259-016-3366-9","article-title":"Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET\/CT","volume":"43","author":"Pfister","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bju.15135","article-title":"68) Ga-PSMA-PET\/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer","volume":"126","author":"Pfister","year":"2020","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.acra.2025.09.004_bib41","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2967\/jnumed.116.173492","article-title":"Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy","volume":"57","author":"Rauscher","year":"2016","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib42","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00330-013-2768-3","article-title":"Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging","volume":"23","author":"Panebianco","year":"2013","journal-title":"Eur Radiol"},{"issue":"12","key":"10.1016\/j.acra.2025.09.004_bib43","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1007\/s00259-021-05620-9","article-title":"Comparing the clinical performance and cost efficacy of [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis","volume":"49","author":"Alberts","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MNM.0000000000000617","article-title":"The role of PSMA PET\/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels","volume":"38","author":"Kabasakal","year":"2017","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib45","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00259-018-4189-7","article-title":"68)Ga-PSMA-11 PET\/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy","volume":"46","author":"Ceci","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/diagnostics7040056","article-title":"Prospective comparison of F-18 Choline PET\/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients","volume":"7","author":"Huysse","year":"2017","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.113.123018","article-title":"Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET\/CT with pelvic multiparametric MR imaging with endorectal coil","volume":"55","author":"Kitajima","year":"2014","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.acra.2025.09.004_bib49","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00259-018-4058-4","article-title":"Prospective comparison of (68)Ga-PSMA PET\/CT, (18)F-sodium fluoride PET\/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer","volume":"45","author":"Zacho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.acra.2025.09.004_bib50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/MNM.0000000000001051","article-title":"Comparison of 18F-Fluciclovine PET\/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer","volume":"40","author":"Chen","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"5","key":"10.1016\/j.acra.2025.09.004_bib51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12094-016-1563-4","article-title":"Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET\/CT) for selecting treatments in recurrent prostate cancer","volume":"19","author":"Conde-Moreno","year":"2017","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3906\/sag-1807-4","article-title":"Comparison of Ga-68 PSMA positron emission tomography\/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients","volume":"49","author":"Uslu-Be\u015fli","year":"2019","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib53","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2012.02.020","article-title":"Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?","volume":"62","author":"Lecouvet","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40644-020-00333-y","article-title":"Does whole-body bone SPECT\/CT provide additional diagnostic information over [18F]-FCH PET\/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?","volume":"20","author":"de Leiris","year":"2020","journal-title":"Cancer Imaging"},{"issue":"21","key":"10.1016\/j.acra.2025.09.004_bib55","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.3390\/cancers13215286","article-title":"Comparison of (68)Ga-prostate specific membrane antigen (PSMA) positron emission tomography computed tomography (PET-CT) and whole-body magnetic resonance imaging (WB-MRI) with diffusion sequences (DWI) in the staging of advanced prostate cancer","volume":"13","author":"Van Damme","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.prnil.2017.05.002","article-title":"Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging","volume":"6","author":"Kwon","year":"2018","journal-title":"Prostate Int"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75589-6","article-title":"Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy","volume":"14","author":"Nikitas","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib58","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2967\/jnumed.123.267017","article-title":"Prospective comparison of (68)Ga-NeoB and (68)Ga-PSMA-R2 PET\/MRI in patients with biochemically recurrent prostate cancer","volume":"65","author":"Duan","year":"2024","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.acra.2025.09.004_bib59","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.2967\/jnumed.123.265916","article-title":"Do bone scans overstage disease compared with PSMA PET at initial staging? An International multicenter retrospective study with masked independent readers","volume":"64","author":"Hope","year":"2023","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib60","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ejrad.2011.01.095","article-title":"Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET\/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)","volume":"81","author":"Panebianco","year":"2012","journal-title":"Eur J Radiol"},{"issue":"10","key":"10.1016\/j.acra.2025.09.004_bib61","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2967\/jnumed.124.267591","article-title":"Clinical factors that influence repeat (68)Ga-PSMA-11 PET\/CT scan positivity in patients with recurrent prostate cancer under observation after a negative (68)Ga-PSMA-11 PET\/CT scan: a single-center retrospective study","volume":"65","author":"Thin","year":"2024","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib62","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00330-018-5682-x","article-title":"68)Ga-PSMA-PET\/CT in comparison with (18)F-fluoride-PET\/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer: a prospective diagnostic accuracy study","volume":"29","author":"Dyrberg","year":"2019","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib63","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00345-016-1948-6","article-title":"Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomy","volume":"35","author":"Lee","year":"2017","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jmir.2023.12.008","article-title":"Diagnostic accuracy of bone scan at different PSA levels in biochemical recurrence of prostate cancer","volume":"55","author":"Singh","year":"2024","journal-title":"J Med Imaging Radiat Sci"},{"issue":"12","key":"10.1016\/j.acra.2025.09.004_bib65","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.purol.2021.04.008","article-title":"Comparison between MRI and choline-PET trans-perineal target biopsies and saturation biopsies for detection and topography of intra-prostatic recurrence after primary radiation therapy for prostate cancer","volume":"31","author":"Biscans","year":"2021","journal-title":"Prog Urol"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib66","first-page":"106","article-title":"Accuracy of (68)Ga-PSMA-11 PET\/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer","volume":"10","author":"Radzina","year":"2020","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib67","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00259-023-06483-y","article-title":"Diagnostic accuracy of fully hybrid [(68)Ga]Ga-PSMA-11 PET\/MRI and [(68)Ga]Ga-RM2 PET\/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial","volume":"51","author":"Ghezzo","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib68","first-page":"266","article-title":"Single-center prospective evaluation of 68Ga-PSMA-11 PET in biochemical recurrence of prostate cancer","volume":"213","author":"Lawhn-Heath","year":"2019","journal-title":"Am\u00a0J\u00a0Roentgenol"},{"issue":"8","key":"10.1016\/j.acra.2025.09.004_bib69","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2967\/jnumed.118.221564","article-title":"68)Ga-PSMA-11 PET\/MR detects local recurrence occult on mpMRI in prostate cancer patients after HIFU","volume":"60","author":"Burger","year":"2019","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.acra.2025.09.004_bib70","first-page":"395","article-title":"Diagnostic scope of (18)F-PSMA-1007 PET\/CT: comparison with multiparametric MRI and bone scintigraphy for the assessment of early prostate cancer recurrence","volume":"11","author":"Saule","year":"2021","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib71","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(24)00069-X","article-title":"68)Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2\/3 imaging trial","volume":"25","author":"Duan","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2025.09.004_bib72","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.5114\/pjr.2024.139007","article-title":"Assessing the effectiveness of MRI, (18)F-fluciclovine PET, SUV(max), and PSA in detecting local recurrence of prostate cancer after prostatectomy","volume":"89","author":"Virarkar","year":"2024","journal-title":"Pol J Radiol"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib73","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2967\/jnumed.118.220103","volume":"60","author":"Emmett","year":"2019","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.acra.2025.09.004_bib74","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1007\/s00330-023-10442-4","article-title":"Recurrent prostate cancer: combined role for MRI and PSMA-PET in (68)Ga-PSMA-11 PET\/MRI","volume":"34","author":"Jannusch","year":"2024","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.acra.2025.09.004_bib75","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1007\/s00259-021-05354-8","article-title":"Patterns of disease detection using [(18)F]DCFPyL PET\/CT imaging in patients with detectable PSA post prostatectomy being considered for salvage radiotherapy: a prospective trial","volume":"48","author":"Koschel","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib76","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2019.11.001","article-title":"A prospective study of 18F-DCFPyL PSMA PET\/CT restaging in recurrent prostate cancer following primary external beam radiotherapy or brachytherapy","volume":"106","author":"Liu","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2025.09.004_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109556","article-title":"PSMA PET\/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: comparison of detection rates and therapeutic implications","volume":"136","author":"Morawitz","year":"2021","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.acra.2025.09.004_bib78","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2967\/jnumed.118.220855","article-title":"Impact of (68)Ga-PSMA PET\/CT on the radiotherapeutic approach to prostate cancer in comparison to CT: a retrospective analysis","volume":"60","author":"Schmidt-Hegemann","year":"2019","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.acra.2025.09.004_bib79","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00259-015-3251-y","article-title":"Biphasic \u2076\u2078Ga-PSMA-HBED-CC-PET\/CT in patients with recurrent and high-risk prostate carcinoma","volume":"43","author":"Sahlmann","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib80","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12094-020-02427-2","article-title":"Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET\/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series","volume":"23","author":"Francolini","year":"2021","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/diagnostics12010195","article-title":"Evaluation of predictors of biochemical recurrence in prostate cancer patients, as detected by (68)Ga-PSMA PET\/CT","volume":"12","author":"Christensen","year":"2022","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib82","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/diagnostics12020349","article-title":"Identification of the optimal cut-off value of PSA for assessing severity of disease in [(68)Ga]Ga-PSMA-11 PET\/CT study in prostate cancer patients after radical prostatectomy","volume":"12","author":"Cegla","year":"2022","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2967\/jnumed.120.261886","article-title":"Diagnostic performance and clinical impact of (68)Ga-PSMA-11 PET\/CT imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA Study)","volume":"63","author":"Cerci","year":"2022","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib84","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/JU.0000000000003493","article-title":"Diagnostic performance and safety of (18)F-rhPSMA-7.3 positron emission tomography in men with suspected prostate cancer recurrence: results from a phase 3, prospective, multicenter study (SPOTLIGHT)","volume":"210","author":"Jani","year":"2023","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2967\/jnumed.124.268151","article-title":"Pattern of failure in patients with biochemical recurrence after PSMA radioguided surgery","volume":"66","author":"Schweiger","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2025.09.004_bib86","article-title":"Comparative evaluation of the performance of 18F-PSMA-1007 PET\/CT and 68Ga-PSMA-11 PET\/CT in prostate cancer patients with biochemical recurrence","author":"Inal","year":"2025","journal-title":"Rev\u00a0Esp\u00a0Med\u00a0Nucl Imagen Mol (Eng\u00a0Ed)"},{"key":"10.1016\/j.acra.2025.09.004_bib87","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251324307","article-title":"18)F]PSMA-1007 PET\/MR as a precision biomarker for early detection of biochemical recurrence in prostate cancer at very low PSA\u00a0levels","volume":"20","author":"Lin","year":"2025","journal-title":"Biomark Insights"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib88","first-page":"197","article-title":"The diagnostic value of PET\/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer","volume":"42","author":"Afshar-Oromieh","year":"2015","journal-title":"Eur\u00a0J\u00a0Nucl\u00a0Med\u00a0Mol\u00a0Imaging"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib89","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jmri.26178","article-title":"Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: preliminary findings","volume":"48","author":"Shiradkar","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.acra.2025.09.004_bib90","article-title":"Contrast-enhanced ultrasound-magnetic resonance imaging radiomics based model for predicting the biochemical recurrence of prostate cancer: a feasibility study","volume":"2022","author":"Wang","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.acra.2025.09.004_bib91","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fonc.2019.00807","article-title":"MRI-derived radiomics to guide post-operative management for high-risk prostate cancer","volume":"9","author":"Bourbonne","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2025.09.004_bib92","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fonc.2020.00731","article-title":"Radiomics of multiparametric MRI to predict biochemical recurrence of localized prostate cancer after radiation therapy","volume":"10","author":"Zhong","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2025.09.004_bib93","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231166766","article-title":"Predicting model of biochemical recurrence of prostate carcinoma (PCa-BCR) using MR perfusion-weighted imaging-based radiomics","volume":"22","author":"An","year":"2023","journal-title":"Technol Cancer Res Treat"},{"issue":"18","key":"10.1016\/j.acra.2025.09.004_bib94","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.3390\/cancers15184437","article-title":"T2-weighted MRI radiomic features predict prostate cancer presence and eventual biochemical recurrence","volume":"15","author":"Duenweg","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib95","doi-asserted-by":"crossref","first-page":"264","DOI":"10.56434\/j.arch.esp.urol.20237604.30","article-title":"MRI-Derived Radiomics Model to Predict the Biochemical Recurrence of Prostate Cancer Following Seed Brachytherapy","volume":"76","author":"Zhu","year":"2023","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.acra.2025.09.004_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.841801","article-title":"Prostate surface distension and tumor texture descriptors from pre-treatment MRI are associated with biochemical recurrence following radical prostatectomy: preliminary findings","volume":"12","author":"Shiradkar","year":"2022","journal-title":"Front Oncol"},{"issue":"23","key":"10.1016\/j.acra.2025.09.004_bib97","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.3390\/jcm12237322","article-title":"Multi-institutional development and validation of a radiomic model to predict prostate cancer recurrence following radical prostatectomy","volume":"12","author":"Huynh","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.acra.2025.09.004_bib98","article-title":"Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib99","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.230143","article-title":"Development and validation of a multimodality model based on whole-slide imaging and biparametric MRI for predicting postoperative biochemical recurrence in prostate cancer","volume":"6","author":"Hu","year":"2024","journal-title":"Radiol Imaging Cancer"},{"issue":"6","key":"10.1016\/j.acra.2025.09.004_bib100","doi-asserted-by":"crossref","first-page":"065035","DOI":"10.1088\/2057-1976\/ad8201","article-title":"Prediction of prostate cancer recurrence after radiotherapy using a fused machine learning approach: utilizing radiomics from pretreatment T2W MRI images with clinical and pathological information","volume":"10","author":"Piran Nanekaran","year":"2024","journal-title":"Biomed Phys Eng Express"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib101","first-page":"891","article-title":"Partial correlation analysis and neural-network-based prediction model for biochemical recurrence of prostate cancer after radical prostatectomy","volume":"13","author":"Kim","year":"2023","journal-title":"Appl\u00a0Sci"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib102","first-page":"1333","article-title":"Prediction system for prostate cancer recurrence using machine learning","volume":"10","author":"Lee","year":"2020","journal-title":"Appl\u00a0Sci"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib103","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/bju.14477","article-title":"Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy","volume":"123","author":"Wong","year":"2019","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib104","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-024-00667-x","article-title":"The practical clinical role of machine learning models with different algorithms in predicting prostate cancer local recurrence after radical prostatectomy","volume":"24","author":"Hu","year":"2024","journal-title":"Cancer Imaging"},{"issue":"4","key":"10.1016\/j.acra.2025.09.004_bib105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/iju.iju_75_24","article-title":"Artificial intelligence in prostate cancer: the potential of machine learning models and neural networks to predict biochemical recurrence after robot-assisted radical prostatectomy","volume":"40","author":"Singh","year":"2024","journal-title":"Indian J Urol"},{"issue":"12","key":"10.1016\/j.acra.2025.09.004_bib106","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3390\/cancers13123098","article-title":"Deep learning with quantitative features of magnetic resonance images to predict biochemical recurrence of radical prostatectomy: a multi-center study","volume":"13","author":"Yan","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.acra.2025.09.004_bib107","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/bioengineering12050538","article-title":"MRMS-CNNFormer: a novel framework for predicting the biochemical recurrence of prostate cancer on multi-sequence MRI","volume":"12","author":"Lian","year":"2025","journal-title":"Bioengineering"},{"key":"10.1016\/j.acra.2025.09.004_bib108","first-page":"14","article-title":"DWI-based biologically interpretable radiomic nomogram for predicting 1- year biochemical recurrence after radical prostatectomy: a deep learning, multicenter study","volume":"21","author":"Niu","year":"2025","journal-title":"Curr Med Imaging"},{"key":"10.1016\/j.acra.2025.09.004_bib109","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejrad.2019.02.028","article-title":"Comparison of PET\/MRI with multiparametric MRI in diagnosis of primary prostate cancer: a\u00a0meta-analysis","volume":"113","author":"Li","year":"2019","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib110","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41391-021-00347-y","article-title":"Preoperative 68Ga-PSMA PET\/CT defines a subgroup of high-risk prostate cancer patients with favorable outcomes after radical prostatectomy and lymph node dissection","volume":"24","author":"Dekalo","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.acra.2025.09.004_bib111","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajur.2020.02.001","article-title":"68)Ga-PSMA PET\/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy","volume":"8","author":"Yuminaga","year":"2021","journal-title":"Asian J Urol"},{"key":"10.1016\/j.acra.2025.09.004_bib112","first-page":"60","article-title":"A survey on deep learning in medical image analysis","volume":"42","author":"Litjens","year":"2017","journal-title":"Med\u00a0Image Analysis"},{"issue":"10","key":"10.1016\/j.acra.2025.09.004_bib113","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1007\/s00259-025-07255-6","article-title":"Long-term outcomes of PSMA PET\/CT-guided radiotherapy in biochemical failure patients post-radical prostatectomy: a 5-year follow-up analysis","volume":"52","author":"Di Giorgio","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.acra.2025.09.004_bib114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2967\/jnumed.123.266527","article-title":"Diagnostic performance of (68)Ga-PSMA-11 PET\/CT versus multiparametric MRI for detection of intraprostatic radiorecurrent prostate cancer","volume":"65","author":"Light","year":"2024","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.acra.2025.09.004_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11604-024-01646-9","article-title":"PSMA PET\/CT imaging and its application to prostate cancer treatment","volume":"43","author":"Otani","year":"2025","journal-title":"Jpn J Radiol"},{"issue":"8","key":"10.1016\/j.acra.2025.09.004_bib116","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2967\/jnumed.125.269996","article-title":"The use of PSMA PET\/CT improves overall survival in men with biochemically recurrent prostate cancer treated with salvage radiotherapy: real-world data from an entire country","volume":"66","author":"Mogensen","year":"2025","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.acra.2025.09.004_bib117","first-page":"995","article-title":"Treatment response evaluation in prostate cancer using PSMA PET\/CT","volume":"66","author":"Gafita","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.acra.2025.09.004_bib118","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000005961","article-title":"Sacral hemangioma mimicking bone metastasis on 18F-PSMA-1007 PET\/CT","author":"Man","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"12","key":"10.1016\/j.acra.2025.09.004_bib119","first-page":"151","article-title":"Prostate multiparametric MRI: evaluation of recurrence and post-treatment changes","volume":"10","author":"Carpagnano","year":"2022","journal-title":"Curr\u00a0Radiol\u00a0Rep"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225008554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225008554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:17:21Z","timestamp":1772882241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633225008554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":119,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1076633225008554"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2025.09.004","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Prostate-Specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities in the Detection of Biochemical Recurrence of Prostate Cancer and Assessment of the Role of Artificial Intelligence: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}